Patents by Inventor Robert A. Cedergren
Robert A. Cedergren has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20180289674Abstract: The presently disclosed subject matter relates to pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof wherein the composition is formulated as a liquid for parenteral administration to a subject, and wherein the composition is disposed within a sealed container as a premixture. The pharmaceutical compositions can be used, for example, in perioperative care of a patient or for sedation.Type: ApplicationFiled: June 8, 2018Publication date: October 11, 2018Applicant: Hospira, Inc.Inventors: Priyanka Roychowdhury, Robert A. Cedergren
-
Publication number: 20180289673Abstract: The presently disclosed subject matter relates to pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof wherein the composition is formulated as a liquid for parenteral administration to a subject, and wherein the composition is disposed within a sealed container as a premixture. The pharmaceutical compositions can be used, for example, in perioperative care of a patient or for sedation.Type: ApplicationFiled: June 8, 2018Publication date: October 11, 2018Applicant: Hospira, Inc.Inventors: Priyanka Roychowdhury, Robert A. Cedergren
-
Patent number: 10016396Abstract: The presently disclosed subject matter relates to pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof wherein the composition is formulated as a liquid for parenteral administration to a subject, and wherein the composition is disposed within a sealed container as a premixture. The pharmaceutical compositions can be used, for example, in perioperative care of a patient or for sedation.Type: GrantFiled: February 28, 2017Date of Patent: July 10, 2018Assignee: HOSPIRA, INC.Inventors: Priyanka Roychowdhury, Robert A. Cedergren
-
Publication number: 20170165235Abstract: The presently disclosed subject matter relates to pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof wherein the composition is formulated as a liquid for parenteral administration to a subject, and wherein the composition is disposed within a sealed container as a premixture. The pharmaceutical compositions can be used, for example, in perioperative care of a patient or for sedation.Type: ApplicationFiled: February 28, 2017Publication date: June 15, 2017Applicant: Hospira, Inc.Inventors: Priyanka Roychowdhury, Robert A. Cedergren
-
Patent number: 9616049Abstract: The presently disclosed subject matter relates to pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof wherein the composition is formulated as a liquid for parenteral administration to a subject, and wherein the composition is disposed within a sealed container as a premixture. The pharmaceutical compositions can be used, for example, in perioperative care of a patient or for sedation.Type: GrantFiled: March 2, 2016Date of Patent: April 11, 2017Assignee: HOSPIRA, INC.Inventors: Priyanka Roychowdhury, Robert A. Cedergren
-
Publication number: 20160175285Abstract: The presently disclosed subject matter relates to pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof wherein the composition is formulated as a liquid for parenteral administration to a subject, and wherein the composition is disposed within a sealed container as a premixture. The pharmaceutical compositions can be used, for example, in perioperative care of a patient or for sedation.Type: ApplicationFiled: March 2, 2016Publication date: June 23, 2016Applicant: Hospira, Inc.Inventors: Priyanka Roychowdhury, Robert A. Cedergren
-
Patent number: 9320712Abstract: The presently disclosed subject matter relates to pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof wherein the composition is formulated as a liquid for parenteral administration to a subject, and wherein the composition is disposed within a sealed container as a premixture. The pharmaceutical compositions can be used, for example, in perioperative care of a patient or for sedation.Type: GrantFiled: February 10, 2014Date of Patent: April 26, 2016Assignee: HOSPIRA, INC.Inventors: Priyanka Roychowdhury, Robert A. Cedergren
-
Publication number: 20140155446Abstract: The presently disclosed subject matter relates to pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof wherein the composition is formulated as a liquid for parenteral administration to a subject, and wherein the composition is disposed within a sealed container as a premixture. The pharmaceutical compositions can be used, for example, in perioperative care of a patient or for sedation.Type: ApplicationFiled: February 10, 2014Publication date: June 5, 2014Applicant: HOSPIRA, INC.Inventors: Priyanka Roychowdhury, Robert A. Cedergren
-
Patent number: 8648106Abstract: The presently disclosed subject matter relates to pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof wherein the composition is formulated as a liquid for parenteral administration to a subject, and wherein the composition is disposed within a sealed container as a premixture. The pharmaceutical compositions can be used, for example, in perioperative care of a patient or for sedation.Type: GrantFiled: April 22, 2013Date of Patent: February 11, 2014Assignee: Hospira, Inc.Inventors: Priyanka Roychowdhury, Robert A. Cedergren
-
Publication number: 20130237576Abstract: The presently disclosed subject matter relates to pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof wherein the composition is formulated as a liquid for parenteral administration to a subject, and wherein the composition is disposed within a sealed container as a premixture. The pharmaceutical compositions can be used, for example, in perioperative care of a patient or for sedation.Type: ApplicationFiled: April 22, 2013Publication date: September 12, 2013Applicant: HOSPIRA, INC.Inventors: Priyanka Roychowdhury, Robert A. Cedergren
-
Patent number: 8455527Abstract: The presently disclosed subject matter relates to pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof wherein the composition is formulated as a liquid for parenteral administration to a subject, and wherein the composition is disposed within a sealed container as a premixture. The pharmaceutical compositions can be used, for example, in perioperative care of a patient or for sedation.Type: GrantFiled: November 15, 2012Date of Patent: June 4, 2013Assignee: Hospira, Inc.Inventors: Priyanka Roychowdhury, Robert A. Cedergren
-
Patent number: 8436033Abstract: The presently disclosed subject matter relates to pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof wherein the composition is formulated as a liquid for parenteral administration to a subject, and wherein the composition is disposed within a sealed container as a premixture. The pharmaceutical compositions can be used, for example, in perioperative care of a patient or for sedation.Type: GrantFiled: November 15, 2012Date of Patent: May 7, 2013Assignee: Hospira, Inc.Inventors: Priyanka Roychowdhury, Robert A. Cedergren
-
Patent number: 8338470Abstract: The presently disclosed subject matter relates to pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof wherein the composition is formulated as a liquid for parenteral administration to a subject, and wherein the composition is disposed within a sealed container as a premixture. The pharmaceutical compositions can be used, for example, in perioperative care of a patient or for sedation.Type: GrantFiled: July 3, 2012Date of Patent: December 25, 2012Assignee: Hospira, Inc.Inventors: Priyanka Roychowdhury, Robert A. Cedergren
-
Patent number: 8242158Abstract: The presently disclosed subject matter relates to pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof wherein the composition is formulated as a liquid for parenteral administration to a subject, and wherein the composition is disposed within a sealed container as a premixture. The pharmaceutical compositions can be used, for example, in perioperative care of a patient or for sedation.Type: GrantFiled: January 4, 2012Date of Patent: August 14, 2012Assignee: Hospira, Inc.Inventors: Priyanka Roychowdhury, Robert A. Cedergren
-
Patent number: 5942395Abstract: New hybrid ribozymes that exhibit the high metabolic stability of small nucleolar ribonucleic acids (snoRNAs), and that cleave target sequences with high efficiencies in either cis (intra-molecular) or trans (inter-molecular) configuration are described. The hybrid ribozymes include (i) a ribozyme catalytic sequence; and (ii) a snoRNA stabilizing motif; wherein the catalytic sequence and the stabilizing motif are arranged to provide the RNA molecule with a three-dimensional configuration in which the catalytic sequence is positioned to interact with a target sequence and the stabilizing motif adopts a conformation that stabilizes the RNA molecule, and additionally enables the RNA molecule to localize in the nucleolus of a cell.Type: GrantFiled: May 9, 1997Date of Patent: August 24, 1999Assignees: Universite de Montreal, University of MassachusettesInventors: Maurille J. Fournier, Dmitry A. Samarsky, Gerardo Ferbeyre, Robert Cedergren